Dopamine infusion enhances the adrenocorticotropic hormone and cortisol response to metoclopramide in hyperprolactinemic patients but not in normal subjects

Gynecological Endocrinology

Volumn 11, Issue 3, 1997, Pages 155-162

  Moro, M ^a   Maraschini, C ^a   Cavagnini, F ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b Instituto Scientifico Ospedale S Luca   (Italy)

Author keywords

ACTH; Cortisol; Dopamine; Hyperprolactinemia; Metoclopramide

Indexed keywords

CORTICOTROPIN; DOPAMINE; HYDROCORTISONE; METOCLOPRAMIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DOPAMINERGIC SYSTEM; DRUG INFUSION; DRUG POTENTIATION; FEMALE; HORMONE RESPONSE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERPROLACTINEMIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; PROLACTINOMA;

EID: 0030979857     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513599709152529     Document Type: Article

References (49)

1. Kooy, A., de Greef, W. J., Vreeburg, J. T. M., Hackneg, W. H. L., Ooms, M. P., Lamberts, S. W. J. and Weber, R. F. A. (1990). Evidence for the involvement of corticotropin-releasing factor in the inhibition of gonadotropin release induced by hyperprolactinemia. Neuroendocrinology, 51, 261-6
2. Taya, K. and Sasamoto, S. (1989). Inhibitory effects of corticotropin-releasing factor and β-endorphin on LH and FSH secretion in the lactating rat. J. Endocrinol., 120, 509-15
3. Vanvugt, D. A., Webb, M. Y. and Reid, R. L. (1989). Naloxone antagonism of corticotropin-releasing hormone stimulation of prolactin secretion in rhesus monkeys. J. Clin. Endocrinol. Metab., 68, 1060-6
4. Morel, G., Enjalbert, A., Proulx, L., Pelletier, G., Barden, N., Grossard, F. and Dubois, P. M. (1989). Effect of corticotropin-releasing factor on the release and synthesis of prolactin. Neuroendocrinology, 49, 669-75
5. Weber, R. F. A. and Calogero, A. E. (1991). Prolactin stimulates rat hypothalamic corticotropin-releasing hormone and pituitary adrenocorticotropin secretion in vitro. Neuroendocrinology, 54, 248-53
6. Naylor, A. M., Porter, D. W. F. and Lincoln, D. W. (1990). Central administration of corticotropin-releasing factor in the sheep: effects on secretion of gonadotropins, prolactin and cortisol. J. Endocrinol., 124, 117-25
7. Rivier, C. and Vale, W. (1985). Effect of the long-term administration of corticotropin-releasing factor on the pituitary-adrenal and pituitary-gonadal axis in the male rat. J. Clin. Invest., 75, 689-94
8. Comtois, R., Beauregard, H., Hardy, J., Robert, F. and Somma, M. (1993). High prolactin levels in patients with Cushing's disease without pathological evidence of pituitary adenoma. Clin. Endocrinol., 38, 601-7
9. Calogero, A. E., Weber, R. F. A., Raid, F., Burrello, N., Moncada, M. L., Mongioi, A. and D'Agata, R. (1994). Involvement of corticotropin-releasing hormone and endogenous opioid peptides in prolactin-suppressed gonadotropin-releasing hormone release in vitro. Neuroendocrinology, 60, 291-6
10. Klemcke, H. G. (1990). Effects of bromocriptine-induced hypoprolactinemia on porcine adrenocortical adrenocorticotropic hormone (ACTH) receptors. 72nd Annual Meeting of the Endocrine Society, Atlanta, 232, p.82
11. Higuchi, K., Nawata, H., Maki, T., Higashizima, M., Kato, K. and Ibayashi, H. (1984). Prolactin has a direct effect on adrenal androgen secretion. J. Clin. Endocrinol. Metab., 59, 714-18
12. Albertson, B. D., Sienkiewicz, M. L., Kimball, D., Munabi, A. K., Cassorla, F. and Loriaux, D. L. (1987). New evidence for a direct effect of prolactin on rat adrenal steroidogenesis. Endocrine Res., 13, 317-33
13. O'Connell, T., McKenna, T. J. and Cunningham, S. K. (1994). The effect of prolactin, human chorionic gonadotropin, insulin and insulin-like growth factor I on adrenal steroidogenesis in isolated guinea-pig adrenal cells. J. Steroid Biochem. Mol. Biol., 48, 235-40
14. McCann, S. M., Pan, G., Xu, R. J., Martinovic, J. and Rettori, V. (1988). Modulatory hypothalamic action of ACTH on ACTH and prolactin release. In Hoshino, K. (ed.) Prolactin Gene Family and its Receptors, p. 211-18. (Amsterdam: Elsevier Science Publishers B.V., Biomedical Division)
15. Schulte, H. M., Chrousos, G. P., Gold, P. W., Oldfield, E. H., Hoban, M. C., Cutler, G. B. and Loriaux, D. L. (1983). Corticotropin-releasing factor (CRF): a common link between anterior pituitary and sympathetic responses to stress. Acta Endocrinol. (Copenh.), 102, 32-3
16. Yamaji, T., Ishibashi, M., Teramoto, A. and Fukushima, T. (1984). Hyperprolactinemia in Cushing's disease and Nelson's syndrome. J. Clin. Endocrinol. Metab., 58, 790-5
17. Luton, J. P., Molinie, P., Stauch, G., Guilhaume, B. and Bricaire, H. (1981). Etude de la TSH et de la prolactine a l'etat de base et sous TRH au cours des syndromes de Cushing et de Nelson. Seminaires de l'Hopital de Paris, 17-18, 841-9
18. Colao, A., Merola, B., Spaziante, R., La Tessa, G., Boudouresque, F., Oliver, C. and Lombardi, G. (1992). Adrenocorticotropic hormone and β-endorphin concentrations in the inferior petrosal sinuses in Cushing's disease and other pituitary diseases. J. Endocrinol. Invest., 15, 807-13
19. Allolio, B., Günther, R. W., Denker, G., Reinwein, D., Winkelmann, W. and Schulte, H. M. (1990). A multihormonal response to corticotropin-releasing hormone in inferior petrosal sinus blood of patients with Cushing's disease. J. Clin. Endocrinol. Metab., 71, 1195-201
20. Vignati, F., Berselli, M. E., Scialfa, G., Boccardi, E. and Loli, P. (1989). Bilateral and simultaneous venous sampling of inferior petrosal sinuses for ACTH and prolactin determination: preoperative localization of ACTH-secreting microadenomas. J. Endocrinol. Invest., 12, 235-8
21. Wiedmann, K., Herzog, L. and Kellner, M. (1995). Atrial natriuretic hormone inhibits corticotropin-releasing hormone-induced prolactin release in man. J. Psychiatr. Res., 29, 51-8
22. Sapun-Malcom, D., Farah, J. M. Jr and Mueller, G. P. (1986). Serotonin and dopamine independently regulate pituitary β-endorphin release in vivo. Neuroendocrinology, 42, 191-6
23. Farah, J. M. Jr and Mueller, G. P. (1989). A D-2 dopaminergic agonist stimulates secretion of anterior pituitary immunoreactive β-endorphin in rats. Neuroendocrinology, 50, 26-32
24. Nishida, S., Matsuki, M., Nagase, Y., Horino, M., Endoh, M., Kakita, K., Tenku, A. and Oyama, H. (1983). Stress-mediated effect of metoclopramide on cortisol secretion in man. J. Clin. Endocrinol. Metab., 56, 839-43
25. Ghigo, E., Goffi, S., Molinatti, G. M., Camanni, F. and Massara, F. (1985). Prolactin and TSH responses to both domperidone and TRH in normal and hyperprolactinemic women after dopamine synthesis blockade. Clin. Endocrinol., 23, 155-60
26. Kovacs, K., Ilse, G. and Ryan, M. (1980). Pituitary prolactin cell hyperplasia. Horm. Res., 12, 87-95
27. Rodriguez-Arnao, M. D., Peters, J. R., Foord, S. M., Dieguez, C., Edwards, C., Gomez-Pan, A., Hall, R., Newcombe, R. G. and Scanlon, M. F. (1983). Exaggerated circadian variation in basal thyrotropin (TSH) and in the dopaminergic inhibition of TSH release in pathological hyperprolactinemia: evidence against a hypothalamic dopaminergic defect. J. Clin. Endocrinol. Metab., 57, 975-80
28. Paradisi, R., Grossi, G., Pintore, A., Venturoli, S., Porcu, E. Capelli, M. and Flamigni, C. (1991). Evidence for a pathological reduction in brain dopamine metabolism in idiopathic hyperprolactinemia. Acta Endocrinol. (Copenh.), 125, 246-52
29. Nicoletti, I., Filipponi, P., Fedeli, L., Ambrosi, F., Giammartino, C., Spinozzi, F. and Santeusanio, F. (1986). Catecholamines and pituitary function. IV. Effects of low-dose dopamine infusion and long-term bromocriptine treatment on the abnormal thyrotroph (TSH) dynamics in patients with pathological hyperprolactinemia. Acta Endocrinol. (Copenh.), 111, 154-61
30. Bansal, S., Lee, L. A. and Woolf, P. D. (1981). Abnormal prolactin responsivity to dopaminergic suppression in hyperprolactinemic patients. Am. J. Med., 71, 961-6
31. Connell, J. M. C., Padfield, P. L., Bunting, E. A., Ball, S. G., Inglis, G. C., Beastall, G. H., Teasdale, G. M. and Davies, D. L. (1983). Inhibition of prolactin secretion by low-dose dopamine infusion in patients with hyperprolactinemia. Clin. Endocrinol., 18, 527-32
32. Maraschini, C., Moro, M., Toja, P., Braga, M. and Cavagnini, F. (1996). No difference between micro- and macroprolactinomas in the prolactin responsiveness to metoclopramide and dopamine administration. Gynecol. Endocrinol., 10, 7-15
33. Kemppainen, R. J., Zerbe, C. A. and Sartin, J. L. (1989). Regulation and secretion of proopiomelanocortin peptides from isolated perfused dog pituitary pars intermedia cells. Endocrinology, 124, 2208-17
34. Kemppainen, R. J. and Sartin, J. L. (1986). In vivo evidence for dopaminergic regulation of the canine pituitary intermediate lobe. Acta Endocrinol. (Copenh.), 113, 471-8
35. Haas, D. A. and George, S. R. (1988). Effect of dopaminergic and alpha-adrenergic modulation on corticotropin-releasing factor immunoreactivity in rat hypothalamus. Can. J. Physiol. Pharmacol., 66, 754-61
36. Plotsky, P. M., Cunningham, S. K. and Widmaier, E. P. (1996). Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion. Endocrin. Rev., 10, 437-58
37. Rots, N. Y., Cools, A. R., Oitzl, M. S., De Jong, J., Sutanto, W. and DeKloet, E. R. (1996). Divergent prolactin and pituitary-adrenal activity in rats selectively bred for different dopamine responsiveness. Endocrinology, 137, 1678-86
38. Nishida, S., Matsuki, M., Adachi, N., Horino, M., Yoneda, M., Endoh, M., Oyama, H., Kikuoka, M., Otsuka, R., Ishii, R. and Andoh, C. (1987). Pituitary-adrenocortical response to metoclopramide in patients with acromegaly and prolactinoma: a clinical evaluation of catecholamine-mediated adrenocorticotropin secretion. J. Clin. Endocrinol. Metab., 64, 995-1001
39. Boesgaard, S., Hagen, C., Nyboe Andersen, A., Fenger, M. and Eldrup, E. (1990). Effect of dopamine, dopamine D-1 and D-2 receptor modulation on ACTH and cortisol levels in normal men and women. Acta Endocrinol. (Copenh.), 122, 29-36
40. Boesgaard, S., Hagen, C., Nyboe Andersen, A., Djursing, H. and Fenger, M. (1988). Cortisol secretion in patients with normoprolactinemic amenorrhea. Acta Endocrinol. (Copenh.), 118, 544-50
41. Murburg, M. M., Wilkinson, C. W., Raskind, M. A., Veith, R. C. and Dorsa, D. M. (1993). Evidence for two differentially regulated populations of peripheral β-endorphin-releasing cells in humans. J. Clin. Endocrinol. Metab., 77, 1033-40
42. Zerbe, C. A., Clark, T. P., Sartin, J. L. and Kemppainen, R. J. (1993). Domperidone treatment enhances corticotropin-releasing hormone stimulated adrenocorticotropic hormone release from the dog pituitary. Neuroendocrinology, 57, 282-8
43. Staessen, J., Fiocchi, R., Bouillon, R., Fagard, R., Lijnen, P., Lissens, W. and Amery, A. (1994). Differential responses of plasma aldosterone, cortisol and adrenocorticotropin to two dopamine receptor antagonists. Meth. Find. Exp. Clin. Pharmacol., 7, 523-7
44. Seki, K. (1989). Variability of cortisol and adrenocorticotropic hormone responses to metoclopramide during the menstrual cycle. Gynecol. Obstet. Invest., 27, 201-3
45. Seki, K., Mitsui, C. and Nagata, I. (1995). Effects of a dopamine antagonist (metoclopramide) on the release of beta-endorphin, ACTH and cortisol in hyperprolactinemic-amenorrheic women. Gynecol. Obstet. Invest., 40, 42-5
46. Ciccarelli, E., Faccani, G., Longo, A., Dalle Ore, G., Papotti, M., Grottoli, S., Razzore, P., Ghè, C. and Muccioli, G. (1995). Prolactin receptors in human pituitary adenomas. Clin. Endocrinol., 42, 487-91
47. Hugues, J. N., Modigliani, E., Girard, F. and Sebaoun, J. (1987). Lack of prolactin involvement in corticosteroid secretion. J. Endocrinol. Invest., 10, 15-20
48. Clapp, D. H. and Wiebe, R. H. (1983). The effect of hyperprolactinemia on the diurnal variation of adrenal androgens. Fertil. Steril., 39, 749-52
49. Carter, J. N., Tyson, J. E., Warne, G. L., McNeilly, A. S., Faiman, C. and Friesen, H. G. (1977). Adrenocortical function in hyperprolactinemic women. J. Clin. Endocrinol. Metab., 45, 973-80